Hepta refractory multiple myeloma is marked by antigen loss, genomic complexity, and 12.8 month median survival in multi centre data.

Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...

Annual meeting moves to the New York Marriott Marquis on October 13-16, marking a new chapter and providing a refreshed ...

Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...

C4 Therapeutics, Inc. (NASDAQ:CCCC) is included in our list of the 7 most volatile stocks under $5 for day trading. As of ...

RTE Late Late Show viewers have praised Dearbhla Mescal after she opened up about a “dark time” in her life. The Irish author joined Co Down host Patrick Kielty on the hit chat show ...

Global market grows at 6.3% CAGR through 2033 as demand rises for safer, targeted chemotherapy treatments worldwide.

Baraka is no stranger to the national spotlight. After he was arrested at Delaney Hall last year when McIver, Menendez and Watson Coleman sought to conduct an oversight visit, his profile as a ...

Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.

Jazz musician whose virtuosic abilities with the clarinet and tenor saxophone straddled traditional and modern jazz ...

The organization presented data aggregated from multiple clinical trials to explore ctDNA's potential as a surrogate endpoint predictive of treatment benefit in lung and other cancers.

Colon cancer survivor Vivian Chee has had three lung surgeries since 2021 but continues to keep fit. Read more at straitstimes.com. Read more at straitstimes.com.